Spatiotemporal delivery strategies for promoting musculoskeletal tissue regeneration

Journal of Bone and Mineral Research

Volumn 24, Issue 9, 2009, Pages 1507-1511

  Guldberg, Robert E ^a  

^a GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Bone regeneration; Delivery strategies; Tissue engineering

Indexed keywords

BIOMATERIAL; BONE MORPHOGENETIC PROTEIN 2; FIBROBLAST GROWTH FACTOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; OSTEOGENIC PROTEIN 1; PEPTIDE; PLATELET DERIVED GROWTH FACTOR; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE; PROTEIN; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN;

ALLOGRAFT; ANGIOGENESIS; AUTOGRAFT; BIOTECHNOLOGICAL PROCEDURES; BONE DEFECT; BONE GROWTH; BONE REMODELING; CANCER SURGERY; CELL STIMULATION; DEGENERATIVE DISEASE; INFECTION; INJURY; MUSCLE TISSUE; REGENERATIVE MEDICINE; REVIEW; STEM CELL TRANSPLANTATION; TISSUE ENGINEERING; TISSUE REGENERATION; VASCULARIZATION; WOUND HEALING IMPAIRMENT;

BIOCOMPATIBLE MATERIALS; HUMANS; MUSCULOSKELETAL PHYSIOLOGICAL PROCESSES; REGENERATION; STEM CELLS;

EID: 72749117438     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.090801     Document Type: Review

References (62)

1. Nerem RM 2006 Tissue engineering: The hope, the hype, and the future. Tissue Eng 12:1143-1150. (Pubitemid 44024487)
2. Lysaght MJ, Jaklenec A, Deweerd E 2008 Great expectations: Private sector activity in tissue engineering, regenerative medicine, and stem cell therapeutics. Tissue Eng Part A 14: 305-315. (Pubitemid 351272557)
3. Porter BD, Lin AS, Peister A, Hutmacher D, Guldberg RE 2007 Noninvasive image analysis of 3D construct mineralization in a perfusion bioreactor. Biomaterials 28:2525-2533. (Pubitemid 46365909)
4. Tuli R, Nandi S, Li WJ, Tuli S, Huang X, Manner PA, Laquerriere P, Noth U, Hall DJ, Tuan RS 2004 Human mesenchymal progenitor cell-based tissue engineering of a single-unit osteochondral construct. Tissue Eng 10:1169-1179. (Pubitemid 39223795)
5. Swiontkowski MF, Aro HT, Donell S, Esterhai JL, Goulet J, Jones A, Kregor PJ, Nordsletten L, Paiement G, Patel A 2006 Recombinant human bone morphogenetic protein-2 in open tibial fractures. A subgroup analysis of data combined from two prospective randomized studies. J Bone Joint Surg Am 88:1258-1265. (Pubitemid 43837120)
6. Wang Y, Wan C, Deng L, Liu X, Cao X, Gilbert SR, Bouxsein ML, Faugere MC, Guldberg RE, Gerstenfeld LC, Haase VH, Johnson RS, Schipani E, Clemens TL 2007 The hypoxia-inducible factor alpha pathway couples angiogenesis to osteogenesis during skeletal development. J Clin Invest 117:1616-1626. (Pubitemid 46871346)
7. Carmeliet P 2003 Blood vessels and nerves: Common signals, pathways and diseases. Nat Rev Genet 4:710-720. (Pubitemid 37046138)
8. Woolf AD, Pfleger B 2003 Burden of major musculoskeletal conditions. Bull World Health Organ 81:646-656.
9. 2008 Evaluation criteria for musculoskeletal and craniofacial tissue engineering constructs: A conference report. Tissue Eng Part A 14:2089-2104.
10. Koefoed M, Ito H, Gromov K, Reynolds DG, Awad HA, Rubery PT, Ulrich-Vinther M, Soballe K, Guldberg RE, Lin AS, O'Keefe RJ, Zhang X, Schwarz EM 2005 Biological effects of rAAV-caAlk2 coating on structural allograft healing. Mol Ther 12:212-218. (Pubitemid 41025090)
11. Berrey BH Jr, Lord CF, Gebhardt MC, Mankin HJ 1990 Fractures of allografts. Frequency, treatment, and end-results. J Bone Joint Surg Am 72:825-833.
12. Awad HA, Zhang X, Reynolds DG, Guldberg RE, O'Keefe RJ, Schwarz EM 2007 Recent advances in gene delivery for structural bone allografts. Tissue Eng 13:1973-1985. (Pubitemid 47293993)
13. Zhang X, Xie C, Lin AS, Ito H, Awad H, Lieberman JR, Rubery PT, Schwarz EM, O'Keefe RJ, Guldberg RE 2005 Periosteal progenitor cell fate in segmental cortical bone graft transplantations: Implications for functional tissue engineering. J Bone Miner Res 20:2124-2137. (Pubitemid 41698776)
14. Ito H, Koefoed M, Tiyapatanaputi P, Gromov K, Goater JJ, Carmouche J, Zhang X, Rubery PT, Rabinowitz J, Samulski RJ, Nakamura T, Soballe K, O'Keefe RJ, Boyce BF, Schwarz EM 2005 Remodeling of cortical bone allografts mediated by adherent rAAV-RANKL and VEGF gene therapy. Nat Med 11:291-297. (Pubitemid 40460557)
15. Harry LE, Sandison A, Paleolog EM, Hansen U, Pearse MF, Nanchahal J 2008 Comparison of the healing of open tibial fractures covered with either muscle or fasciocutaneous tissue in a murine model. J Orthop Res 26:1238-1244.
16. Claes L, Maurer-Klein N, Henke T, Gerngross H, Melnyk M, Augat P 2006 Moderate soft tissue trauma delays new bone formation only in the early phase of fracture healing. J Orthop Res 24:1178-1185. (Pubitemid 43870879)
17. Utvag SE, Grundnes O, Rindal DB, Reikeras O 2003 Influence of extensive muscle injury on fracture healing in rat tibia. J Orthop Trauma 17:430-435. (Pubitemid 36939331)
18. Masquelet AC 2003 Muscle reconstruction in reconstructive surgery: Soft tissue repair and long bone reconstruction. Langenbecks Arch Surg 388:344-346.
19. Bruder SP, Kurth AA, Shea M, Hayes WC, Jaiswal N, Kadiyala S 1998 Bone regeneration by implantation of purified, culture-expanded human mesenchymal stem cells. J Orthop Res 16:155-162. (Pubitemid 28249153)
20. Bruder SP, Kraus KH, Goldberg VM, Kadiyala S 1998 The effect of implants loaded with autologous mesenchymal stem cells on the healing of canine segmental bone defects. J Bone Joint Surg Am 80:985-996. (Pubitemid 28355669)
21. Granero-Molto F, Weis JA, Miga MI, Landis B, Myers TJ, O'Rear L, Longobardi L, Jansen ED, Mortlock DP, Spagnoli A 2009 Regenerative effects of transplanted mesenchymal stem cells in fracture healing. Stem Cells 27:1887-1898.
22. Vats A, Tolley NS, Polak JM, Gough JE 2003 Scaffolds and biomaterials for tissue engineering: A review of clinical applications. Clin Otolaryngol Allied Sci 28:165-172. (Pubitemid 36763586)
23. Muschler GF, Nakamoto C, Griffith LG 2004 Engineering principles of clinical cell-based tissue engineering. J Bone Joint Surg Am 86:1541-1558. (Pubitemid 38886548)
24. Hill E, Boontheekul T, Mooney DJ 2006 Designing scaffolds to enhance transplanted myoblast survival and migration. Tissue Eng 12:1295-1304. (Pubitemid 44024499)
25. Schmitt JM, Winn SR, Hollinger JO 1999 Bone morphogenetic proteins: An update on basic biology and clinical relevance. J Orthopaed Res 17:269-278. (Pubitemid 29190501)
26. Reddi AH 1994 Bone and cartilage differentiation. Curr Opin Genet Dev 4:737-744.
27. Riley JML, Urist MR, Lyons KM, Lieberman JR 1996 Bone morphogenetic protein-2: Biology and applications. Clin Orthop Relat Res 324:39-46.
28. Wozney JM 1989 Bone morphogenetic proteins. Prog Growth Factor Res 1:267-280.
29. Kato HT, Namikawa T, Hoshino M, Terai H, Miyamoto S, Takaoka K 2006 Optimized use of a biodegradable polymer as a carrier material for the local delivery of recombinant human bone morphogenetic protein-2 (rhBMP-2). Biomaterials 27: 2035-2041. (Pubitemid 41759497)
30. Xu JL, Tang T, Ng KW, Zhang J, Yu C, Dai K 2005 Evaluation of different scaffolds for BMP-2 genetic orthopedic tissue engineering. J Biomed Mater Res B 75:289-303. (Pubitemid 41609549)
31. Lieberman AD, Einhorn TA 2002 The role of growth factors in the repair of bone: Biology and clinical applications. J Bone Joint Surg Am 84:1032-1044. (Pubitemid 34907256)
32. Cook MWW, Salkeld SL, Rueger DC 1995 Effect of recombinant human osteogenic protein-1 on healing of segmental defects in non-human primates. J Bone Joint Surg Am 77:734-750.
33. Bostrom NPC 1998 Potential role of bone morphogenetic proteins in fracture healing. Clin Orthop Relat Res 355S: S274-S282. (Pubitemid 28538539)
34. Nordsletten L 2006 Recent developments in the use of bone morphogenetic protein in orthopaedic trauma surgery. Curr Med Res Opin 22(Suppl 1):S13-S17. (Pubitemid 44298364)
35. Kofron MD, Laurencin CT 2006 Bone tissue engineering by gene delivery. Adv Drug Deliv Rev 58:555-576. (Pubitemid 43928172)
36. Cahill KS, Chi JH, Day A, Claus EB 2009 Prevalence, complications, and hospital charges associated with use of bonemorphogenetic proteins in spinal fusion procedures. JAMA 302:58-66.
37. Chen ZW, Sun H, Wu H, Xin S, Wang Q, Dong G, Ma Z, Huang S, Zhang Y, Jin Y 2006 Release of bioactive BMP from dextran-derived microspheres: A novel delivery concept. Int J Pharmaceutics 307:23-32. (Pubitemid 41773248)
38. Huang BC, Wulur I, Rudkin G, Ishida K, Wu B, Yamaguchi DT, Miller TA 2004 BMP-2 exerts differential effects on differentiation of rabbit bone marrow stromal cells grown in two-dimensional and three-dimensional systems and is required for in vitro bone formation in a PLGA scaffold. Exp Cell Res 299:325-334. (Pubitemid 39179800)
39. Jeon O, Song SJ, Yang HS, Bhang SH, Kang SW, Sung MA, Lee JH, Kim BS 2008 Long-term delivery enhances in vivo osteogenic efficacy of bone morphogenetic protein-2 compared to short-term delivery. Biochem Biophys Res Commun 369:774-780.
40. Street J, Bao M, deGuzman L, Bunting S, Peale FV Jr, Ferrara N, Steinmetz H, Hoeffel J, Cleland JL, Daugherty A, van Bruggen N, Redmond HP, Carano RA, Filvaroff EH 2002 Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover. Proc Natl Acad Sci USA 99:9656-9661. (Pubitemid 34831103)
41. Carlevaro MF, Cermelli S, Cancedda R, Descalzi Cancedda F 2000 Vascular endothelial growth factor (VEGF) in cartilage neovascularization and chondrocyte differentiation: Auto-paracrine role during endochondral bone formation. J Cell Sci 113:59-69. (Pubitemid 30066333)
42. Hausman MR, Schaffler MB, Majeska RJ 2001 Prevention of fracture healing in rats by an inhibitor of angiogenesis. Bone 29:560-564.
43. Stewart DJ, Kutryk MJ, Fitchett D, Freeman M, Camack N, Su Y, Della Siega A, Bilodeau L, Burton JR, Proulx G, Radhakrishnan S 2009 VEGF gene therapy fails to improve perfusion of ischemic myocardium in patients with advanced coronary disease: Results of the NORTHERN trial. Mol Ther 17:1109-1115.
44. Li R, Stewart DJ, von Schroeder HP, Mackinnon ES, Schemitsch EH 2009 Effect of cell-based VEGF gene therapy on healing of a segmental bone defect. J Orthop Res 27:8-14.
45. Shen X, Wan C, Ramaswamy G, Mavalli M, Wang Y, Duvall CL, Deng LF, Guldberg RE, Eberhart A, Clemens TL, Gilbert SR 2009 Prolyl hydroxylase inhibitors increase neoangiogenesis and callus formation following femur fracture in mice. J Orthop Res (in press).
46. Wan C, Gilbert SR, Wang Y, Cao X, Shen X, Ramaswamy G, Jacobsen KA, Alaql ZS, Eberhardt AW, Gerstenfeld LC, Einhorn TA, Deng L, Clemens TL 2008 Activation of the hypoxia-inducible factor-1alpha pathway accelerates bone regeneration. Proc Natl Acad Sci USA 105:686-691. (Pubitemid 351171769)
47. Simmons CA, Alsberg E, Hsiong S, Kim WJ, Mooney DJ 2004 Dual growth factor delivery and controlled scaffold degradation enhance in vivo bone formation by transplanted bone marrow stromal cells. Bone 35:562-569. (Pubitemid 38953205)
48. Oest ME, Dupont KM, Kong HJ, Mooney DJ, Guldberg RE 2007 Quantitative assessment of scaffold and growth factor-mediated repair of critically sized bone defects. J Orthop Res 25:941-950.
49. Huang YC, Kaigler D, Rice KG, Krebsbach PH, Mooney DJ 2005 Combined angiogenic and osteogenic factor delivery enhances bone marrow stromal cell-driven bone regeneration. J Bone Miner Res 20:848-857. (Pubitemid 40571642)
50. Rai B, Oest ME, Dupont KM, Ho KH, Teoh SH, Guldberg RE 2007 Combination of platelet-rich plasma with polycaprolactonetricalcium phosphate scaffolds for segmental bone defect repair. J Biomed Mater Res A 81:888-899. (Pubitemid 46835084)
51. Kempen DH, Lu L, Heijink A, Hefferan TE, Creemers LB, Maran A, Yaszemski MJ, Dhert WJ 2009 Effect of local sequential VEGF and BMP-2 delivery on ectopic and orthotopic bone regeneration. Biomaterials 30:2816-2825.
52. Biau DJ, Pannier S, Masquelet AC, Glorion C 2009 Case report: Reconstruction of a 16-cm diaphyseal defect after Ewing's resection in a child. Clin Orthop Relat Res 467: 572-577.
53. Pelissier P, Masquelet AC, Bareille R, Pelissier SM, Amedee J 2004 Induced membranes secrete growth factors including vascular and osteoinductive factors and could stimulate bone regeneration. J Orthop Res 22:73-79. (Pubitemid 38043892)
54. Johnson MR, Lee HJ, Bellamkonda RV, Guldberg RE 2009 Sustained release of BMP-2 in a lipid-based microtube vehicle. Acta Biomater 5:23-28.
55. Chen B, Lin H, Zhao Y, Wang B, Zhao Y, Liu Y, Liu Z, Dai J 2007 Activation of demineralized bone matrix by genetically engineered human bone morphogenetic protein-2 with a collagen binding domain derived from von Willebrand factor propolypeptide. J Biomed Mater Res A 80:428-434. (Pubitemid 46122677)
56. Schmoekel HG, Weber FE, Schense JC, Gratz KW, Schawalder P, Hubbell JA 2005 Bone repair with a form of BMP-2 engineered for incorporation into fibrin cell ingrowth matrices. Biotechnol Bioeng 89:253-262. (Pubitemid 40288876)
57. Wernike E, Hofstetter W, Liu Y, Wu G, Sebald HJ, Wismeijer D, Hunziker EB, Siebenrock KA, Klenke FM 2009 Long-term cell-mediated protein release from calcium phosphate ceramics. J Biomed Mater Res A (in press).
58. Lee SJ 2000 Cytokine delivery and tissue engineering. Yonsei Med J 41:704-719.
59. Meilander NJ, Yu X, Ziats NP, Bellamkonda RV 2001 Lipid-based microtubular drug delivery vehicles. J Control Release 71:141-152. (Pubitemid 32195448)
60. Benoit DS, Anseth KS 2005 Heparin functionalized PEG gels that modulate protein adsorption for hMSC adhesion and differentiation. Acta Biomater 1:461-470.
61. Silva EA, Mooney DJ 2007 Spatiotemporal control of vascular endothelial growth factor delivery from injectable hydrogels enhances angiogenesis. J Thromb Haemost 5:590-598.
62. Kolambkar YM, Dupont KM, Mooney DJ, Hutmacher DW, Guldberg RE 2009 Effect of nanofiber mesh design on BMP-mediated segmental bone defect repair. 55th Annual Meeting of the Orthopaedic Research Society, Las Vegas, NV, February 22-25, 2009.